AbCellera announced that the United States Patent and Trademark Office’s Patent Trial and Appeal Board has denied a rehearing request in an Inter Partes Review filed by Berkeley Lights, Inc. Berkeley Lights that challenged AbCellera’s U.S. Patent No. 10,087,408. AbCellera’s ‘408 Patent is directed to microfluidic devices and using such devices to culture cells, monitor a response, and recover selected cells, an important part of AbCellera’s end-to-end monoclonal antibody development engine.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
